Vaccines in Pregnant Women and Research Initiatives
Author:
- 1 June 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Obstetrics and Gynecology
- Vol. 55 (2) , 474-486
Abstract
Successful maternal immunization requires consideration of maternal and infant disease burden, biological factors affecting immune response and placental transport of antibodies, optimal timing of immunization, safety and acceptability. Tetanus, inactivated influenza and acellular pertussis vaccines are recommended during pregnancy; others are recommended when maternal risk of infection is high. The development of new conjugate vaccines for use in adults may reduce global maternal and infant disease burden. Maternal immunization against group B streptococcus is projected to be superior to current preventative strategies in decreasing disease. Further evaluation of maternal immunization strategies to prevent maternal and infant infections is needed.Keywords
This publication has 14 references indexed in Scilit:
- Impact of maternal immunization on influenza hospitalizations in infantsAmerican Journal of Obstetrics and Gynecology, 2011
- Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births: A Retrospective Cohort StudyPLOS Medicine, 2011
- How to Communicate With Vaccine-Hesitant ParentsPediatrics, 2011
- Effectiveness of Maternal Influenza Immunization in Mothers and InfantsNew England Journal of Medicine, 2008
- Maternal ImmunizationThe Pediatric Infectious Disease Journal, 2007
- The Influence of Maternal Immunization on Infant Immune ResponsesJournal of Comparative Pathology, 2007
- Risks and benefits of immunizing pregnant women: The risk of doing nothingReproductive Toxicology, 2006
- Role of Maternal Pertussis Antibodies in InfantsThe Pediatric Infectious Disease Journal, 2005
- Maternal immunization with Haemophilus influenzae type b vaccines in different populationsVaccine, 2003
- Immunization of pregnant women: reproductive, medical and societal risksVaccine, 2003